Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibition
Giorgio Corti(Candiolo Cancer Institute), Sabrina Arena(Candiolo Cancer Institute)
Cited by 5
Related Papers
Emergence of Multiple <i>EGFR</i> Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer
|Clinical Cancer Research|2015|273
Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer
|Clinical Cancer Research|2019|77